Spots Global Cancer Trial Database for atm
Every month we try and update this database with for atm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency | NCT02975934 | Metastatic Cast... | Rucaparib Abiraterone ace... | 18 Years - | pharmaand GmbH | |
Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients | NCT05002140 | Metastasis Locally Advance... Recurrent Cance... | XRD-0394 Palliative radi... | 18 Years - | XRad Therapeutics Inc | |
A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency | NCT02975934 | Metastatic Cast... | Rucaparib Abiraterone ace... | 18 Years - | pharmaand GmbH | |
Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC) | NCT03075735 | Prostate Cancer | 18 Years - 99 Years | Centro Nacional de Investigaciones Oncologicas CARLOS III | ||
Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC) | NCT03075735 | Prostate Cancer | 18 Years - 99 Years | Centro Nacional de Investigaciones Oncologicas CARLOS III | ||
Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients | NCT05002140 | Metastasis Locally Advance... Recurrent Cance... | XRD-0394 Palliative radi... | 18 Years - | XRad Therapeutics Inc | |
Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC) | NCT03075735 | Prostate Cancer | 18 Years - 99 Years | Centro Nacional de Investigaciones Oncologicas CARLOS III | ||
Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients | NCT05002140 | Metastasis Locally Advance... Recurrent Cance... | XRD-0394 Palliative radi... | 18 Years - | XRad Therapeutics Inc |